Clinical Trials Directory

Trials / Completed

CompletedNCT01779778

Diurnal and Nocturnal Effect of Travatan With SofZia Preservative on Intraocular Pressure and Ocular Perfusion Pressure

The Diurnal and Nocturnal Effect of Travatan With SofZia Preservative on Intraocular Pressure and Ocular Perfusion Pressure

Status
Completed
Phase
Study type
Observational
Enrollment
40 (actual)
Sponsor
University of Colorado, Denver · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

The purpose of this research study is to determine the diurnal and nocturnal effects of Travoprost with SofZia (Travatan Z) on intraocular pressure and ocular perfusion pressure.

Detailed description

The investigators hypothesize that Travatan Z will significantly lower intraocular pressure and increase ocular perfusion pressure during both the diurnal and nocturnal period, during a 24-hour evaluation, compared to baseline. The investigators further hypothesize that the medication effects will persist at 72 hours after discontinuation of the drug.

Conditions

Timeline

Start date
2012-04-01
Primary completion
2013-04-01
Completion
2013-04-01
First posted
2013-01-30
Last updated
2016-08-02

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01779778. Inclusion in this directory is not an endorsement.